25 related articles for article (PubMed ID: 19331146)
1. Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway.
Bae S; Bae S; Kim HS; Lim YJ; Kim G; Park IC; So KA; Kim TJ; Lee JH
Cancer Manag Res; 2024; 16():507-525. PubMed ID: 38827785
[TBL] [Abstract][Full Text] [Related]
2. Cancer resistance via the downregulation of the tumor suppressors
Moghaddam M; Vivarelli S; Falzone L; Libra M; Bonavida B
Explor Target Antitumor Ther; 2023; 4(2):170-207. PubMed ID: 37205308
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic Induction of Mitochondria-Anchored Aggregation-Induced Emission Luminogens through the Intrinsic Mitochondrial Pathway.
Zhang H; Zhang Z; Wang S; Qiu T; Xu T; Shu Y
ACS Omega; 2022 Dec; 7(51):47912-47922. PubMed ID: 36591127
[TBL] [Abstract][Full Text] [Related]
4. Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer.
Santha S; Ling X; Aljahdali IAM; Rasam SS; Wang X; Liao J; Wang J; Fountzilas C; Li Q; Qu J; Li F
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33217967
[TBL] [Abstract][Full Text] [Related]
5. Biochemical significance of limonene and its metabolites: future prospects for designing and developing highly potent anticancer drugs.
Mukhtar YM; Adu-Frimpong M; Xu X; Yu J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30287506
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Apoptosis in a Breast Cancer Cell Line after IL-10 Silencing.
Alotaibi MR; Hassan ZK; Al-Rejaie SS; Alshammari MA; Almutairi MM; Alhoshani AR; Alanazi WA; Hafez MM; Al-Shabanah OA
Asian Pac J Cancer Prev; 2018 Mar; 19(3):777-783. PubMed ID: 29582634
[TBL] [Abstract][Full Text] [Related]
7. AIEgen-based theranostic system: targeted imaging of cancer cells and adjuvant amplification of antitumor efficacy of paclitaxel.
Chen C; Song Z; Zheng X; He Z; Liu B; Huang X; Kong D; Ding D; Tang BZ
Chem Sci; 2017 Mar; 8(3):2191-2198. PubMed ID: 28507673
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.
Sabbineni H; Alwhaibi A; Goc A; Gao F; Pruitt A; Somanath PR
Eur J Pharmacol; 2015 Oct; 764():208-214. PubMed ID: 26148825
[TBL] [Abstract][Full Text] [Related]
9. Prediction of functional phosphorylation sites by incorporating evolutionary information.
Niu S; Wang Z; Ge D; Zhang G; Li Y
Protein Cell; 2012 Sep; 3(9):675-90. PubMed ID: 22802047
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation.
Radnai B; Antus C; Racz B; Engelmann P; Priber JK; Tucsek Z; Veres B; Turi Z; Lorand T; Sumegi B; Gallyas F
Mol Cancer; 2012 May; 11():34. PubMed ID: 22583868
[TBL] [Abstract][Full Text] [Related]
11. The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.
Chon HS; Marchion DC; Xiong Y; Chen N; Bicaku E; Stickles XB; Bou Zgheib N; Judson PL; Hakam A; Gonzalez-Bosquet J; Wenham RM; Apte SM; Lancaster JM
Gynecol Oncol; 2012 Jan; 124(1):119-24. PubMed ID: 22032837
[TBL] [Abstract][Full Text] [Related]
12. Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt inactivation, Bad activation, and mitochondrial dysfunction.
Kuo CT; Hsu MJ; Chen BC; Chen CC; Teng CM; Pan SL; Lin CH
Toxicol Lett; 2008 Feb; 177(1):48-58. PubMed ID: 18262737
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.
MacKeigan JP; Taxman DJ; Hunter D; Earp HS; Graves LM; Ting JP
Clin Cancer Res; 2002 Jul; 8(7):2091-9. PubMed ID: 12114408
[TBL] [Abstract][Full Text] [Related]
14. Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-kappaB activation but not GSK3beta activity.
Bhattacharya S; Ray RM; Johnson LR
Apoptosis; 2005 Aug; 10(4):759-76. PubMed ID: 16133867
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis.
Zhang R; Banik NL; Ray SK
Brain Res; 2008 Nov; 1239():216-25. PubMed ID: 18804099
[TBL] [Abstract][Full Text] [Related]
16. Critical role of bad phosphorylation by Akt in cytostatic resistance of human bladder cancer cells.
Szanto A; Bognar Z; Szigeti A; Szabo A; Farkas L; Gallyas F
Anticancer Res; 2009 Jan; 29(1):159-64. PubMed ID: 19331146
[TBL] [Abstract][Full Text] [Related]
17. PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol.
Szanto A; Hellebrand EE; Bognar Z; Tucsek Z; Szabo A; Gallyas F; Sumegi B; Varbiro G
Biochem Pharmacol; 2009 Apr; 77(8):1348-57. PubMed ID: 19426673
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
